Disclaimer: This is a user generated content submitted by a member of the WriteUpCafe Community. The views and writings here reflect that of the author and not of WriteUpCafe. If you have any complaints regarding this post kindly report it to us.

Off-site, modular construction minimizes disruption to building timelines and logistical delays, ensuring systematic delivery of new facilities, this is particularly beneficial within the healthcare industry, where speed, sanitation and sterility are crucial

Roots Analysis is pleased to announce the publication of its recent study, titled, “Modular Facilities in Pharmaceutical and Biotechnology Market

The report features an extensive study of the current market landscape and future potential of the players engaged in offering services for modular facility construction for biotechnology and pharmaceutical industries. The study presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. Amongst other elements, the report features:

An in-depth review of the market landscape of players that offer services for modular facility construction for biotechnology and pharmaceutical industries, along with the details of certifications obtained and COVID-19 related initiatives undertaken by modular service providers.

A review of the market landscape of modular cleanrooms along with information on their year of establishment, company size, location of headquarters, type of industry served, type of modular cleanrooms, type of modular cleanroom components. It also includes details related to regulatory approvals and certifications.

An analysis of the partnerships that have been inked by stakeholders in this domain, during the period between 2012 and 2021.

An in-depth analysis of modular projects undertaken across key geographical regions, featuring information on type of facility, facility area, most active manufacturers, most active clients, location of facility.

An insightful analysis on facility construction trends in the pharmaceutical industry for the last five years, highlighting facility construction projects established by top 20 pharma / biotech players.

Elaborate profiles of key players that provide a wide range of modular manufacturing solutions to pharmaceutical and biotechnology industries.

An in-depth review of emerging trends, including processing technologies with modular facilities, the shift towards smaller, multi-purpose modular facilities, and technological advancements in modular construction processes.

A detailed discussion on the various growth drivers and trends related to modular solutions in emerging markets by pharmaceutical / biopharmaceutical CMOs.

  • A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

To Request Sample Pageshttps://www.rootsanalysis.com/reports/178/request-sample.html

Type of Modular Construct

Hybrid Skid

Plug-and-Play

Skid-Mounted

Truckable

Others

Type of Construction Component

Base Building

Electrical System

Mechanical System

Process Equipment

Process Piping

Process Utilities

Other Components

Purpose of Facility

Aseptic Filling

Manufacturing

Research and Development

Others

Facility Area

Very Small

Small

Mid-Sized

Large

Very Large

Scale of Operation

Clinical

Commercial

Type of Industry

Pharmaceutical                   

Biotechnology

Type of Product

Biosimilars             

Cell and Gene Therapies

Monoclonal Antibodies

Vaccines

Other Products

  • Type of Facility
  • New Facility
  • Facility Expansions

Key Geographical Regions

North America                    

Europe

Asia

Middle East and North Africa

Latin America

Rest of the World

Download Free Insights nowhttps://www.rootsanalysis.com/reports/178/free-insights.html

Transcripts of interviews held with the following senior level representatives of stakeholder companies

Alan de Zayas (Modular Building Manufacturing and Construction Team, Avon Modular Construction)

François Abiven (Executive Vice-President Global Business Unit BLS and Luca Mussati Vice President, Pharma and Biotech Life Sciences, Exyte)

Maik Jornitz (President and Chief Executive Officer, G-CON Manufacturing)

Pär Almhem (President, Modwave)

Sulogna Roy (Ex Sales Manager, Zeton)

Vernon Solomon (Specialist in Modular Design for Cleanrooms and Close Tolerance Temperature and Humidity Control, Environmental Systems Corporation)

Key companies covered in the report

  • Cytiva

G-CON Manufacturing

Pharmadule Morimatsu

NNE

IPM Technologies

KeyPlants

Germfree Laboratories

ModuleCO Pharma

For more information, please click on the following link

https://www.rootsanalysis.com/reports/view_document/modular-facilities-flexible-drug-manufacturing-platforms-of-the-future/178.html

You may also be interested in the following titles:

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com

 

Login

Welcome to WriteUpCafe Community

Join our community to engage with fellow bloggers and increase the visibility of your blog.
Join WriteUpCafe